Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
68.94
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
39,521
Open
68.94
Bid (Size)
68.87 (10)
Ask (Size)
68.90 (3)
Prev. Close
68.94
Today's Range
68.94 - 68.94
52wk Range
52.65 - 76.56
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
Today 8:45 EDT
Read the latest report on NanoViricides here
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Performance
YTD
-0.56%
-0.56%
1 Month
+0.44%
+0.44%
3 Month
-3.89%
-3.89%
6 Month
+0.31%
+0.31%
1 Year
+30.03%
+30.03%
More News
Read More
Baidu To Rally Over 29%? Here Are 10 Other Analyst Forecasts For Monday
September 25, 2023
Via
Benzinga
Argenx's 28% Surge & Promising Product Propel Investor Confidence
September 25, 2023
Via
MarketBeat
3 Magnificent Growth Stocks to Buy Right Now
September 24, 2023
Via
The Motley Fool
AstraZeneca Surges To 50-Day Line After Breast Cancer Drug Tops Chemo
September 22, 2023
Via
Investor's Business Daily
Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting
September 22, 2023
Via
Benzinga
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
September 22, 2023
From
AstraZeneca
Via
Business Wire
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
September 20, 2023
Via
FinancialNewsMedia
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers – Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
September 15, 2023
Via
Benzinga
AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
September 14, 2023
From
AstraZeneca
Via
Business Wire
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
September 11, 2023
Via
Benzinga
FASENRA met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
September 11, 2023
From
AstraZeneca
Via
Business Wire
Qualcomm-Apple's Chip Supply Agreement, Alleged Report About AstraZeneca CEO Sir Pascal Soriot's Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories
September 11, 2023
Via
Benzinga
What's Going On With AstraZeneca Stock Today?
September 11, 2023
Via
Benzinga
AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials
September 11, 2023
Via
Benzinga
TAGRISSO® (osimertinib) Plus Chemotherapy Extended Median Progression-free Survival by Nearly 9 Months in EGFR-mutated Advanced Lung Cancer in FLAURA2 Phase III Trial
September 11, 2023
From
AstraZeneca
Via
Business Wire
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial
September 11, 2023
From
AstraZeneca
Via
Business Wire
4 Top-Tier Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 09, 2023
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population
September 06, 2023
Via
Benzinga
FDA Seeks Further Safeguards for AstraZeneca's Ultomiris Therapy, But Efficacy Not in Question
September 06, 2023
Via
Benzinga
Exposures
Product Safety
3 Forever Stocks to Buy With $100
September 05, 2023
Via
The Motley Fool
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
Via
Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
Via
Benzinga
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.